Michael S Blaiss, MD in Roswell, GA - Allergy & Immunology

Michael S Blaiss, MD is a Allergy & Immunology physician based in Roswell, Georgia. Michael S Blaiss is licensed to practice in Tennessee (license number MD00010264) and his current practice location is 1090 Windfaire Pl, Roswell, Georgia. He can be reached at his office (for appointments etc.) via phone at (901) 674-6075.

NPI number for Michael S Blaiss is 1891720108 and his current mailing address is 1090 Windfaire Pl, Roswell, Georgia. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1891720108.

Contact Information

	Michael S Blaiss, MD
	1090 Windfaire Pl, Roswell, GA 30076-3307
	(901) 674-6075
	Not Available

Physician's Profile

Full Name	Michael S Blaiss
Gender	Male
Speciality	Allergy & Immunology
Location	1090 Windfaire Pl, Roswell, Georgia
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1891720108
Provider Enumeration Date: 07/12/2006
Last Update Date: 01/22/2019

Medical Identifiers

Medical identifiers for Michael S Blaiss such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1891720108	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207K00000X	Allergy & Immunology	MD00010264 (Tennessee)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael S Blaiss is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Michael S Blaiss, MD 1090 Windfaire Pl, Roswell, GA 30076-3307 Ph: (901) 674-6075	Michael S Blaiss, MD 1090 Windfaire Pl, Roswell, GA 30076-3307 Ph: (901) 674-6075

News Archive

Protect Your Manhood, ZERO collaborate to address prostate health

ZERO – The End of Prostate Cancer is partnering with Protect Your Manhood, a New Hampshire seacoast based start-up founded by prostatitis survivor and marketing maven Chris Sargent, which offers a culturally relevant resource to promote prostate health.

Binge-drinking from adolescence could have long-term effects on the cardiovascular system

Moderate drinking has been linked to a lower risk of coronary heart disease in several studies. However, the relationship between alcohol and heart disease remains controversial and is challenging to assess.

Lifestyle intervention shows kidney benefits in diabetic patients

A lifestyle intervention focused on weight loss and increasing physical activity should be considered as additional treatment to prevent advanced kidney disease in overweight or obese people with Type 2 diabetes, say researchers.

Enrollment complete in Alnylam's ALN-RSV01 Phase IIb study for RSV infection

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has completed patient enrollment in its Phase IIb study with ALN-RSV01, an RNAi therapeutic for the treatment of respiratory syncytial virus (RSV) infection.

Study identifies new classes of breast stem cells responsible for mammary gland development

Publication in Nature advanced on line publication : researchers at the Université libre de Bruxelles, ULB identify distinct types of stem cells that contribute to mammary gland development and maintenance.

Michael S Blaiss, MD - Allergy & Immunology in Roswell, GA